Cloning of carrier cells infected with oncolytic adenovirus driven by midkine promoter and biosafety studies

BACKGROUND: A549 carrier cells infected with oncolytic adenovirus can induce complete tumor reduction of subcutaneous ovarian tumors but not intraperitoneal disseminated ovarian tumors. This appears to be a result of the insufficient antitumor effect of A549 carrier cells. Therefore, in the present...

Descripción completa

Detalles Bibliográficos
Autores principales: Hamada, Katsuyuki, Takagi, Soichi, Kuboshima, Hajime, Shimada, Hideaki, Takagi, Kazuko, Yasuoka, Toshiaki, Matsubara, Keiichi, Sassa, Yukiko, Furuya, Tetsuya, Suzuki, Kazuhiko, Uchide, Tsuyoshi, Mizutani, Tetsuya, Tani, Kenzaburo, Itoh, Hiroshi, Sugiyama, Takashi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6590659/
https://www.ncbi.nlm.nih.gov/pubmed/30548997
http://dx.doi.org/10.1002/jgm.3064

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6590659/
https://www.ncbi.nlm.nih.gov/pubmed/30548997
http://dx.doi.org/10.1002/jgm.3064

Ejemplares similares